Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Kartos Therapeutics Inc.
Sponsor

Kartos Therapeutics Inc.

United States 275 Shoreline Drive Suite 300, 94065-1490, United States

About the sponsor

Clinical research in advanced and recurrent endometrial cancer, with attention to TP53 wild-type disease and maintenance therapy strategies.

  • Advanced or recurrent endometrial cancer
  • TP53 wild-type tumour biology
  • Maintenance treatment

Interest centres on disease control in patients with persistent or returning endometrial malignancy.

About Specializations

Kartos Therapeutics Inc. runs clinical trials in conditions such as Myelofibrosis, Primary myelofibrosis, Endometrial cancer, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

4 clinical trials

Myelofibrosis

Recruiting
Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Navtemadlin
  • Sponsor:Kartos Therapeutics Inc.

Myelofibrosis+1

Recruiting
Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Navtemadlin
  • Sponsor:Kartos Therapeutics Inc.

Myelofibrosis+1

Not recruiting
Registered drugNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Danazol
  • Sponsor:Kartos Therapeutics Inc.

Endometrial cancer

Not recruiting
Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Loperamide
  • Sponsor:Kartos Therapeutics Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.